A new trading day began on Friday, with Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) stock price down -12.72% from the previous day of trading, before settling in for the closing price of $1.12. RVPH’s price has ranged from $0.60 to $6.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 40.40%. With a float of $28.44 million, this company’s outstanding shares have now reached $33.44 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Reviva Pharmaceuticals Holdings Inc is 14.94%, while institutional ownership is 21.86%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.44 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.40% per share during the next fiscal year.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Trading Performance Indicators
Here are Reviva Pharmaceuticals Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.30, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc (RVPH)
Looking closely at Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH), its last 5-days average volume was 0.32 million, which is a drop from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 8.89%. Additionally, its Average True Range was 0.14.
During the past 100 days, Reviva Pharmaceuticals Holdings Inc’s (RVPH) raw stochastic average was set at 38.92%, which indicates a significant increase from 3.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 115.18% in the past 14 days, which was lower than the 124.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2276, while its 200-day Moving Average is $2.1517. However, in the short run, Reviva Pharmaceuticals Holdings Inc’s stock first resistance to watch stands at $1.0987. Second resistance stands at $1.2200. The third major resistance level sits at $1.2899. If the price goes on to break the first support level at $0.9075, it is likely to go to the next support level at $0.8376. Now, if the price goes above the second support level, the third support stands at $0.7163.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Key Stats
With a market capitalization of 28.53 million, the company has a total of 33,441K Shares Outstanding. Currently, annual sales are 0 K while annual income is -39,260 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,860 K.
